Effects Of Diltiazem On Human Nicotinic Acetylcholine And Gaba(A) Receptors

Department

neurobiology

Document Type

Article

Abstract

Effects of the L-type calcium channel antagonist diltiazem on recombinant human GABA(A) receptor (α1β2γ2s) or on muscle (α1β1δγ and α1β1δε) or neuronal (α7 and α4β2) nicotinic acetylcholine receptors expressed in Xenopus oocytes were examined using two-electrode voltage-clamp. Diltiazem inhibited the function of both muscle and neuronal nicotinic receptors, but it had no effect on GABA(A) receptors. The extent of functional inhibition of nicotinic receptors depended on the receptor subtype, and the order of inhibition potency by diltiazem was α7>α4β2≃α1β1δγ≃α1β1δε. Inhibition of α7 receptor function was non-competitive and voltage-independent, and it occurred at concentrations far lower than those needed to inhibit (never completely) binding of 125I-α-bungarotoxin to heterologously expressed α7 receptors in mammalian cells. Pre-incubation in diltiazem before concomitant application with acetylcholine increased inhibition of function and slowed recovery from inhibition. Verapamil, a phenylalkylamine antagonist of L-type Ca2+ channels also fully inhibited α7 receptor function and partially inhibited 125I-α-bungarotoxin binding to α7 receptors, but was less potent than diltiazem. Effects on both α7 receptor function and 125I-α-bungarotoxin binding by verapamil plus diltiazem suggest separate sites for verapamil and diltiazem on α7 receptors. These results provide further evidence that L-type Ca2+ channel drugs inhibit ligand-gated cationic channels and suggest that caution should be applied when using these compounds to study systems in which L-type Ca2+ channels and ligand-gated cationic channels co-exist. Copyright (C) 2000 Elsevier Science Ltd.

Publication Date

10-18-2000

Publication Title

Neuropharmacology

ISSN

00283908

Volume

39

Issue

13

First Page

2533

Last Page

2542

Digital Object Identifier (DOI)

10.1016/S0028-3908(00)00116-7

This document is currently not available here.

Share

COinS